Graham Capital Management’s Ventyx Biosciences VTYX Stock Holding History

Graham Capital Management’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,381	Closed	-$292K	–	1538
2025 Q4	$292K	Sell	32,381 -126,682	-80%	-$947K	0.01%	867
2025 Q3	$495K	Buy	159,063 +114,691	+258%	+$304K	0.01%	619
2025 Q2	$95K	Sell	44,372 -173,274	-80%	-$280K	﹤0.01%	1206
2025 Q1	$250K	Buy	+217,646	New	+$374K	﹤0.01%	1057
2024 Q4	–	Sell	-50,956	Closed	-$111K	–	1503
2024 Q3	$111K	Sell	50,956 -169,973	-77%	-$391K	﹤0.01%	999
2024 Q2	$510K	Buy	+220,929	New	+$918K	0.01%	583
2024 Q1	–	Sell	-463,117	Closed	-$1.14M	–	1323
2023 Q4	$1.14M	Buy	+463,117	New	+$4.4M	0.03%	358

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Graham Capital Management's VTYX Position: Q1 2026 in Review

Graham Capital Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 32,381 shares — an estimated $292K sold.

Graham Capital Management first reported a position in VTYX in Q4 2023 and held it in 7 quarters. The position peaked at $1.14M in Q4 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Graham Capital Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Graham Capital Management sold 32,381 Ventyx Biosciences shares in Q1 2026, an estimated $292K.
Graham Capital Management first reported a position in Ventyx Biosciences in Q4 2023 and held it in 7 quarters.
Graham Capital Management's Ventyx Biosciences position peaked at $1.14M in Q4 2023.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.